Literature DB >> 9194441

Value of single-voxel proton MR spectroscopy in temporal lobe epilepsy.

E Achten1, P Boon, T Van De Kerckhove, J Caemaert, J De Reuck, M Kunnen.   

Abstract

PURPOSE: To study the value of different parameters derived from single-voxel proton MR spectroscopy of the mesial temporal lobes in the lateralization of the epileptogenic zone in patients with temporal lobe epilepsy.
METHODS: We studied 12 healthy volunteers and 21 patients with temporal lobe epilepsy refractory to medical treatment, which was clearly lateralized with electroencephalography (EEG) and MR imaging. The mesial temporal lobes were investigated with single-voxel proton MR spectroscopy using a point-resolved spectroscopic sequence with an echo time of 135 milliseconds. The normalized concentration of N-acetylaspartate (NAA), creatine (Cr), and choline-containing compounds (Cho), and the metabolite ratios NAA/Cho+Cr, NAA/Cr, Cho/Cr, and NAA/Cho were calculated from the spectra. Using these values and an asymmetry index, we assigned the patients to one of five lateralization categories.
RESULTS: The most consistent MR spectroscopic parameter for clear lateralization was the NAA/Cho+Cr ratio, followed by the NAA ratio. But with an adequate asymmetry index, the epilepsy in 17 (81%) of 21 patients could be lateralized by EEG and MR imaging with both parameters concordantly. Symmetric bilateral abnormalities were found in four of the 21 patients with NAA/Cho+Cr and in only one of the 21 patients with NAA. With both parameters, no contradictory lateralization was found; however, this was indeed the case with the remaining ratios, NAA/Cr, Cho/Cr, and NAA/Cho, in two, three, and one of the patients, respectively. A statistically significant decrease in NAA was found on the epileptic side, but also on the contralateral side.
CONCLUSION: With an adequate asymmetry index, NAA/Cho+Cr and NAA are equally sensitive in predicting the side of involvement in patients with unilateral temporal lobe epilepsy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9194441      PMCID: PMC8337306     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  7 in total

1.  Lateralization of temporal lobe epilepsy using a novel uncertainty analysis of MR diffusion in hippocampus, cingulum, and fornix, and hippocampal volume and FLAIR intensity.

Authors:  Mohammad-Reza Nazem-Zadeh; Jason M Schwalb; Kost V Elisevich; Hassan Bagher-Ebadian; Hajar Hamidian; Ali-Reza Akhondi-Asl; Kourosh Jafari-Khouzani; Hamid Soltanian-Zadeh
Journal:  J Neurol Sci       Date:  2014-05-16       Impact factor: 3.181

2.  Proton MR spectroscopy in patients with acute temporal lobe seizures.

Authors:  M Castillo; J K Smith; L Kwock
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

Review 3.  Utility of magnetic resonance spectroscopic imaging for human epilepsy.

Authors:  Jullie W Pan; Ruben I Kuzniecky
Journal:  Quant Imaging Med Surg       Date:  2015-04

Review 4.  [(1)H MR spectroscopy. Methods and applications in diagnosis and assessment of surgical and conservative treatment strategies in epilepsies].

Authors:  T Hammen; H Stefan
Journal:  Nervenarzt       Date:  2004-10       Impact factor: 1.214

Review 5.  1H MR spectroscopy in patients with mesial temporal epilepsy.

Authors:  M Hájek; M Dezortová; V Komárek
Journal:  MAGMA       Date:  1998-12       Impact factor: 2.310

6.  Value of Proton-MR-Spectroscopy in the Diagnosis of Temporal Lobe Epilepsy; Correlation of Metabolite Alterations With Electroencephalography.

Authors:  Hasan Aydin; Nilay Aydin Oktay; Volkan Kizilgoz; Elif Altin; Idil Gunes Tatar; Baki Hekimoglu
Journal:  Iran J Radiol       Date:  2012-03-25       Impact factor: 0.212

7.  DTI-based response-driven modeling of mTLE laterality.

Authors:  Mohammad-Reza Nazem-Zadeh; Kost Elisevich; Ellen L Air; Jason M Schwalb; George Divine; Manpreet Kaur; Vibhangini S Wasade; Fariborz Mahmoudi; Saeed Shokri; Hassan Bagher-Ebadian; Hamid Soltanian-Zadeh
Journal:  Neuroimage Clin       Date:  2015-10-30       Impact factor: 4.881

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.